A share price of Aspen Aerogels Inc. [ASPN] is currently trading at $17.18, up 0.35%. An important factor to consider is whether the stock is rising or falling in short-term value. The ASPN shares have gain 1.96% over the last week, with a monthly amount glided 47.47%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 12, February 2024, Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Business Highlights. In a post published today on Yahoo Finance, $84.2 million quarterly revenue enabled gross margins of 35% and adjusted EBITDA of $9.1 million.
From an analyst’s perspective:
Aspen Aerogels Inc. [NYSE: ASPN] stock has seen the most recent analyst activity on March 20, 2023, when The Benchmark Company upgraded its rating to a Buy but kept the price target unchanged to $14 for it. On December 10, 2021, The Benchmark Company initiated with a Buy rating and assigned a price target of $70 on the stock. Cowen started tracking the stock assigning a Outperform rating and suggested a price target of $8 on October 14, 2021. Piper Sandler initiated its recommendation with a Overweight and recommended $58 as its price target on September 10, 2021. Oppenheimer started tracking with a Outperform rating for this stock on August 17, 2021, and assigned it a price target of $51. In a note dated July 15, 2021, Seaport Global Securities initiated an Buy rating and provided a target price of $45 on this stock.
Aspen Aerogels Inc. experienced fluctuations in its stock price throughout the past year between $5.32 and $18.12. Currently, Wall Street analysts expect the stock to reach $27.33 within the next 12 months. Aspen Aerogels Inc. [NYSE: ASPN] shares were valued at $17.18 at the most recent close of the market. An investor can expect a potential return of 59.08% based on the average ASPN price forecast.
Analyzing the ASPN fundamentals
Trailing Twelve Months sales for Aspen Aerogels Inc. [NYSE:ASPN] were 238.72M which represents 41.28% growth. Gross Profit Margin for this corporation currently stands at 0.24% with Operating Profit Margin at -0.21%, Pretax Profit Margin comes in at -0.19%, and Net Profit Margin reading is -0.18%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.1 and Total Capital is -0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.66 points at the first support level, and at 16.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.88, and for the 2nd resistance point, it is at 18.57.
Aspen Aerogels Inc. [ASPN] reported earnings per share of -$0.01 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.12/share, meaning a difference of $0.11 and a surprise factor of 91.70%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.19 per share as compared to estimates of -$0.27 per share, a difference of $0.08 representing a surprise of 29.60%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Aspen Aerogels Inc. [NYSE:ASPN] is 3.41. On the other hand, the Quick Ratio is 2.91, and the Cash Ratio is 1.79. Considering the valuation of this stock, the price to sales ratio is 5.49, the price to book ratio is 2.94.
Transactions by insiders
Recent insider trading involved Landes Gregg, SVP, Operations and Strat Deve, that happened on Nov 20 when 155.0 shares were sold. Director, Mitchell Steven R completed a deal on Sep 07 to buy 7541.0 shares. Meanwhile, Director Mitchell Steven R bought 50000.0 shares on Sep 05.
